Tamil Nadu Braces for Extended Heatwave With Temperatures Exceeding 40C Health Advisory Issued Market Pricing Shifts Sharply as Hot Inflation Report Fuels Speculation of Fed Rate Hike Ashok Leyland Q4 PAT Hits Record 1405 Crore Board Declares 250 Dividend Robotic Garment Manufacturing Automation Could Reshape Global Apparel Supply Chains Bahrain Minister Hails UKGulf Trade Deal as Monumental Achievement IRS Settlement Blocks Tax Audits on Trump and Family Businesses NTLA Q1 2026 Earnings NarrowerThanExpected Loss Fuels Optimism in Gene Editing Pipeline EDBL Q1 2026 Earnings Widening Losses and Stock Decline Reflect Challenging Quarter Perspective Therapeutics Inc CATX Q1 2026 Earnings NarrowerthanExpected Loss Amid Clinical Progress MAIN Q1 2026 Earnings EPS Misses Estimates as Net Investment Income Declines Novagold Resources NG Q1 2026 Earnings Narrower Loss Surpasses Estimates Amid Precious Metals Focus BZAI Q1 2026 Earnings EPS Beat Amid Revenue Discontinuation Shares Surge Perimeter Acquisition Corp I Warrant PMTRW Holds Steady at 077 Amid Low Activity TIM SA TIMB Edges Lower as Telecom Sector Faces ProfitTaking American Drive Acquisition Co ADAC Holds Steady Near 994 as SPAC Investors Eye Key Levels SC II Acquisition Corp Units Hold Steady at 1018 Amid Low Volume Agora Inc API Holds Steady Near Support Eyes Resistance Amid LowVolume Trading Flipkart Achieves Record 200 Million in SingleDay Sales Marking ECommerce Milestone SO Q1 2026 Earnings EPS Surges Past Estimates Stock Slips Slightly Fate Therapeutics Surges Over 10 as Biotech Sector Shows Signs of Life FATE MQ Q1 2026 Earnings Massive EPS Beat of 745 Surprises Analysts OHI Q1 2026 Earnings EPS Surpasses Estimates Amid Minimal Stock Movement LUV Q1 2026 Earnings EPS Falls Short of Expectations Amid Operating Headwinds BUD Q1 2026 Earnings EPS Beats Estimates by 815 Yet Shares Slip AST SpaceMobile Q1 2026 Earnings EPS Misses Estimates as PreRevenue Company Advances Satellite Network Bicycle Therapeutics BCYC Q1 2026 Earnings WiderthanExpected Loss as Pipeline Development Continues Alzamend Neuro Inc ALZN Q1 2026 Earnings NarrowerthanExpected Loss as EarlyStage Biotech Continues RD Focus